These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 7922221

  • 1. Edematous disorders: pathophysiology of renal sodium and water retention and treatment with diuretics.
    Abraham WT, Schrier RW.
    Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):798-805. PubMed ID: 7922221
    [Abstract] [Full Text] [Related]

  • 2. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
    Schrier RW.
    Am J Med; 2006 Jul; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
    [Abstract] [Full Text] [Related]

  • 3. Body fluid volume regulation in health and disease.
    Abraham WT, Schrier RW.
    Adv Intern Med; 1994 Jul; 39():23-47. PubMed ID: 8140955
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of water and sodium retention in cirrhosis.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun; 59():S43-9. PubMed ID: 9185104
    [Abstract] [Full Text] [Related]

  • 5. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 6. Use of diuretics in heart failure and cirrhosis.
    Schrier RW.
    Semin Nephrol; 2011 Nov; 31(6):503-12. PubMed ID: 22099507
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2).
    Schrier RW.
    N Engl J Med; 1988 Oct 27; 319(17):1127-34. PubMed ID: 3050523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pathophysiology of vasopressin in edematous disorders.
    Schrier RW, Howard RL.
    Nihon Naibunpi Gakkai Zasshi; 1989 Dec 20; 65(12):1311-27. PubMed ID: 2697604
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis of sodium and water retention in liver disease.
    Niederberger M, Schrier RW.
    Prog Liver Dis; 1992 Dec 20; 10():329-47. PubMed ID: 1296235
    [Abstract] [Full Text] [Related]

  • 11. Pathophysiology of water and sodium retention: edematous states with normal kidney function.
    Bekheirnia MR, Schrier RW.
    Curr Opin Pharmacol; 2006 Apr 20; 6(2):202-7. PubMed ID: 16483846
    [Abstract] [Full Text] [Related]

  • 12. Treatment of edematous disorders with diuretics.
    Rasool A, Palevsky PM.
    Am J Med Sci; 2000 Jan 20; 319(1):25-37. PubMed ID: 10653442
    [Abstract] [Full Text] [Related]

  • 13. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
    Peña JC.
    Rev Invest Clin; 1995 Jan 20; 47(1):63-79. PubMed ID: 7777718
    [Abstract] [Full Text] [Related]

  • 14. [Mechanisms of renal retention of sodium and water in heart failure, cirrhosis and pregnancy].
    Knotek M, Rogachev B, Ohara M, Schrier RW.
    Lijec Vjesn; 2000 Jan 20; 122(1-2):20-6. PubMed ID: 10916353
    [Abstract] [Full Text] [Related]

  • 15. Sodium and water retention in heart failure: pathogenesis and treatment.
    Martin PY, Schrier RW.
    Kidney Int Suppl; 1997 Jun 20; 59():S57-61. PubMed ID: 9185106
    [Abstract] [Full Text] [Related]

  • 16. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S, Lindenfeld J, Schrier RW.
    Circ Heart Fail; 2009 Jul 20; 2(4):370-6. PubMed ID: 19808361
    [Abstract] [Full Text] [Related]

  • 17. Decreased effective blood volume in edematous disorders: what does this mean?
    Schrier RW.
    J Am Soc Nephrol; 2007 Jul 20; 18(7):2028-31. PubMed ID: 17568020
    [Abstract] [Full Text] [Related]

  • 18. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1322-30. PubMed ID: 18179782
    [Abstract] [Full Text] [Related]

  • 19. [Diuretic-resistant edema].
    Shiikai T, Ideura T, Matsui N, Koshikawa S.
    Nihon Rinsho; 1974 Aug 15; 32(8):2619-28. PubMed ID: 4612208
    [No Abstract] [Full Text] [Related]

  • 20. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov 15; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.